Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 Polymorphism

NCT04455906 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT04455906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04455906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 Polymorphism
Lead sponsor
Boston Children's Hospital
Phase
Observational
Overall status
Recruiting
Start date
November 30, 2020
Completion date
September 15, 2027
Enrollment
111 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis